Clifford Chance has advised Fresenius Kabi on the sale of its subsidiary Laboratorio Sanderson S.A. in Chile to Medifarma.
Laboratorio Sanderson S.A. holds a manufacturing plant of injectable products and other liquid substances for medical applications in Santiago de Chile. Medifarma, a multinational pharmaceutical company from Peru with a strong presence in Latin America, will continue the manufacturing of the existing portfolio of products in Chile.
The Clifford Chance team advising Fresenius Kabi was led by partner Javier Amantegui, together with senior associate Beatriz Melo and associate Andreína Velásquez and supported by associate Sofía Albiñana.